Il y a eu 50 transactions d'initiés récentes enregistrées pour Fusion Pharmaceuticals Inc. (FUSN), dont 32 achats et 14 ventes. Le total des achats d'initiés s'élève à $1.35M et le total des ventes d'initiés à $1.35M.
Les initiés notables ayant une activité récente comprennent Cagnoni Pablo J, Duncan Barbara Gayle, Leamon Christopher P. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — FUSN
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-06-04 |
Cagnoni Pablo J |
Director |
Restitution d'Actions |
141,011 |
$2.35 |
$331.38K |
- |
| 2024-06-04 |
Duncan Barbara Gayle |
Director |
Restitution d'Actions |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Leamon Christopher P |
Chief Scientific Officer |
Restitution d'Actions |
63,700 |
- |
- |
- |
| 2024-06-04 |
Meek David D. |
Director |
Restitution d'Actions |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-06-04 |
Crowley John J |
Chief Financial Officer |
Restitution d'Actions |
63,700 |
- |
- |
- |
| 2024-06-04 |
Gannon Steven |
Director |
Restitution d'Actions |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Bergstrom Donald A |
Director |
Restitution d'Actions |
34,000 |
$10.59 |
$360.06K |
- |
| 2024-06-04 |
Valliant John |
Chief Executive Officer |
Restitution d'Actions |
192,200 |
- |
- |
- |
| 2024-06-04 |
Burak Eric |
Chief Technology Officer |
Restitution d'Actions |
63,700 |
- |
- |
- |
| 2024-06-04 |
Lee Philina |
Director |
Restitution d'Actions |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Bender Jeremy |
Director |
Restitution d'Actions |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-06-04 |
Rawat Mohit |
President & Cbo |
Restitution d'Actions |
81,300 |
- |
- |
- |
| 2024-06-04 |
Bobilev Dmitri |
Chief Medical Officer |
Restitution d'Actions |
91,000 |
- |
- |
- |
| 2024-06-04 |
Bitetti Teresa Marie |
Director |
Restitution d'Actions |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-01-04 |
Leamon Christopher P |
Chief Scientific Officer |
Attribution de RSU |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Crowley John J |
Chief Financial Officer |
Attribution de RSU |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Valliant John |
Chief Executive Officer |
Attribution de RSU |
192,200 |
- |
- |
192,200 |
| 2024-01-04 |
Burak Eric |
Chief Technology Officer |
Attribution de RSU |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Rawat Mohit |
President & Cbo |
Attribution de RSU |
81,300 |
- |
- |
81,300 |
| 2024-01-04 |
Bobilev Dmitri |
Chief Medical Officer |
Attribution de RSU |
91,000 |
- |
- |
91,000 |
| 2023-10-16 |
Meek David D. |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-10-16 |
Meek David D. |
Director |
Attribution de RSU |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-10-16 |
Bender Jeremy |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-10-16 |
Bender Jeremy |
Director |
Attribution de RSU |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-10-16 |
Bitetti Teresa Marie |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-10-16 |
Bitetti Teresa Marie |
Director |
Attribution de RSU |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-08-31 |
Leamon Christopher P |
Chief Scientific Officer |
Attribution de RSU |
11,957 |
- |
- |
11,957 |
| 2023-08-31 |
Rawat Mohit |
President & Cbo |
Attribution de RSU |
12,843 |
- |
- |
12,843 |
| 2023-06-14 |
Cagnoni Pablo J |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Duncan Barbara Gayle |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Preston Heather |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Khuong Chau Quang |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Gannon Steven |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Bergstrom Donald A |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Lee Philina |
Director |
Attribution de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-01-05 |
Leamon Christopher P |
Chief Scientific Officer |
Attribution de RSU |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Crowley John J |
Chief Financial Officer |
Attribution de RSU |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Valliant John |
Chief Executive Officer |
Attribution de RSU |
500,000 |
- |
- |
500,000 |
| 2023-01-05 |
Burak Eric |
Chief Technology Officer |
Attribution de RSU |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Rawat Mohit |
President and Cbo |
Attribution de RSU |
300,000 |
- |
- |
300,000 |
| 2022-11-11 |
Khuong Chau Quang |
Director |
Attribution de RSU |
42,093 |
$2.38 |
$100.18K |
42,093 |
| 2022-11-07 |
Bobilev Dmitri |
Officer |
Inconnu |
- |
- |
- |
- |
| 2022-11-07 |
Bobilev Dmitri |
Chief Medical Officer |
Attribution de RSU |
550,000 |
- |
- |
550,000 |
| 2022-08-11 |
Gannon Steven |
Director |
Achat Informatif |
44,400 |
$2.03 |
$90.13K |
56,400 |
| 2022-06-14 |
Cagnoni Pablo J |
Director |
Attribution de RSU |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Duncan Barbara Gayle |
Director |
Attribution de RSU |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Preston Heather |
Director |
Attribution de RSU |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Khuong Chau Quang |
Director |
Attribution de RSU |
17,000 |
$3.60 |
$61.2K |
17,000 |
| 2022-06-14 |
Gannon Steven |
Director |
Attribution de RSU |
17,000 |
$3.60 |
$61.2K |
17,000 |
| 2022-06-14 |
Bergstrom Donald A |
Director |
Attribution de RSU |
17,000 |
$3.60 |
$61.2K |
17,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi